Taurine in non-alcoholic fatty liver disease treatment
AbstractIn double-blind, placebo-controlled clinical trial taurine clinical efficacy in patients with non-alcoholic fatty liver disease and diabetes mellitus type 2 was evaluated. The results of this study have shown effects of taurine on lipid and carbohydrate metabolism and also that taurine is a typical hepatoprotector.
Keywords:non-alcoholic fatty liver disease, taurine, complex conservative prevention
Endocrinology: News, Opinions, Training. 2014; (3): 96–102.